No Data
Critical Insights From Enovis Analyst Ratings: What You Need To Know
In the latest quarter, 4 analysts provided ratings for Enovis (NYSE:ENOV), showcasing a mix of bullish and bearish perspectives.The following table encapsulates their recent ratings, offering a glimps
Enovis Is Maintained at Outperform by Evercore ISI Group
Enovis Is Maintained at Outperform by Evercore ISI Group
Evercore Maintains Enovis Corp(ENOV.US) With Buy Rating, Cuts Target Price to $62
Evercore analyst Vijay Kumar maintains $Enovis Corp(ENOV.US)$ with a buy rating, and adjusts the target price from $64 to $62.According to TipRanks data, the analyst has a success rate of 47.4% and a
Top 3 Health Care Stocks That Could Blast Off In June
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator, which compares a stock's strength on days when prices go u
Enovis Initiated at Neutral by JP Morgan
Enovis Initiated at Neutral by JP Morgan
J.P. Morgan Initiates Enovis Corp(ENOV.US) With Hold Rating, Announces Target Price $53
J.P. Morgan analyst Robbie Marcus initiates coverage on $Enovis Corp(ENOV.US)$ with a hold rating, and sets the target price at $53.According to TipRanks data, the analyst has a success rate of 53.9%